Becker's Healthcare November 19, 2024
As the medical device industry looks ahead to potential policies under the new administration, key decisions could shape the future of innovation, regulation and reimbursement in this sector.
Here are four factors to watch:
- During the first Trump administration, an executive order aimed to streamline Medicare coverage for FDA authorized “breakthrough devices” targeting life threatening conditions. These devices would have received four years of coverage to help manufacturers gather necessary evidence for permanent reimbursement. However, the policy was not implemented and was later scrapped by the Biden administration. As a result, industry advocates hope that the new Trump administration will revisit and expand Medicare coverage for breakthrough devices, The Wall Street Journal reported Nov. 14.
- If...
Today's Sponsors
Today's Sponsor